NORTEM BIOGROUP overview

Nortem BioGroup (EPA:MLBIO) (MLBIO.PA), a Euronext-listed company and a leader in the European food biotechnology sector, has released its annual results for the 2023 financial year. Interested investors can download them at https://investors.nortembiogroup.com/wp-content/uploads/2024/09/Financial-Report-2023.pdf. SAFE HARBOR This press release contains statements regarding the future of Nortem Biogroup and its innovations. Statements regarding the future may be accompanied by words such as...

Nortem Biougroup (EPA:MLBIO) has update its Investor Presentation. Investors, stakeholders and members of the media are invited to download it in this link: https://investors.nortembiogroup.com/wp-content/uploads/2023/10/FINAL-EQUITY-STORY-Nortem-BioGroup.pdf...

Paris, 20 October - Euronext-listed Nortem BioGroup (EPA:MLBIO) (MLBIO.PA), a leader in the European food biotechnology industry, has drafted plans to increasing its production of organic probiotics designed to combat intestinal disorders and treat age-related skin conditions, due to growing consumer demand. The company, already commercializing over 200 products, plants to unroll new probiotic lines in the incoming months under the brand name NaturalPharma Laboratories, and all of them produced...

Paris, 27 September - Food technology company Nortem BioGroup (EPA:MLBIO) (MLBIO.PA), began trading today on Euronext Paris at a valuation of EUR 12.9 million and a price of EUR 5.00 per share. The company floated 2,578,500 shares under the stock exchange symbol MLBIO. The traditional bell-ringing ceremony at the Euronext's headquarters in La Défense was presided by the company's founder and Executive President, José Luis Vázquez. After the ceremony, Vázquez said that "today is a historic...